Combined antifungal resistance and biofilm tolerance: the global threat of Candida auris

Ryan Kean, Gordon Ramage

Research output: Contribution to journalArticle

10 Downloads (Pure)

Abstract

The enigmatic yeast Candida auris has emerged over the last decade and rapidly penetrated into our consciousness. The global threat from this multidrug resistant yeast has generated a call to arms from within the medical mycology community. Over the past decade our understanding of how this yeast has spread globally, its clinical importance, and how it tolerates and resists antifungal agents has expanded. This review highlights the clinical importance of antifungal resistance in C. auris and explores our current understanding of the mechanisms associated with azole, polyene and echinocandin resistance. We also discuss the impact of phenotypic tolerance, with particular emphasis on biofilm mediated resistance, and present new pipelines of antifungal drugs that promise new hope in the management of C. auris infection.
Original languageEnglish
JournalmSphere
Publication statusPublished - 31 Jul 2019

Fingerprint

Biofilms
Candida
Yeasts
Echinocandins
Mycology
Polyenes
Azoles
Antifungal Agents
Consciousness
Infection
Pharmaceutical Preparations

Cite this

@article{ceaff5f654dc4458a6e82b6932ca6695,
title = "Combined antifungal resistance and biofilm tolerance: the global threat of Candida auris",
abstract = "The enigmatic yeast Candida auris has emerged over the last decade and rapidly penetrated into our consciousness. The global threat from this multidrug resistant yeast has generated a call to arms from within the medical mycology community. Over the past decade our understanding of how this yeast has spread globally, its clinical importance, and how it tolerates and resists antifungal agents has expanded. This review highlights the clinical importance of antifungal resistance in C. auris and explores our current understanding of the mechanisms associated with azole, polyene and echinocandin resistance. We also discuss the impact of phenotypic tolerance, with particular emphasis on biofilm mediated resistance, and present new pipelines of antifungal drugs that promise new hope in the management of C. auris infection.",
author = "Ryan Kean and Gordon Ramage",
note = "Acceptance in SAN OA article",
year = "2019",
month = "7",
day = "31",
language = "English",
journal = "mSphere",
issn = "2379-5042",
publisher = "American Society for Microbiology",

}

Combined antifungal resistance and biofilm tolerance: the global threat of Candida auris. / Kean, Ryan; Ramage, Gordon.

In: mSphere, 31.07.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Combined antifungal resistance and biofilm tolerance: the global threat of Candida auris

AU - Kean, Ryan

AU - Ramage, Gordon

N1 - Acceptance in SAN OA article

PY - 2019/7/31

Y1 - 2019/7/31

N2 - The enigmatic yeast Candida auris has emerged over the last decade and rapidly penetrated into our consciousness. The global threat from this multidrug resistant yeast has generated a call to arms from within the medical mycology community. Over the past decade our understanding of how this yeast has spread globally, its clinical importance, and how it tolerates and resists antifungal agents has expanded. This review highlights the clinical importance of antifungal resistance in C. auris and explores our current understanding of the mechanisms associated with azole, polyene and echinocandin resistance. We also discuss the impact of phenotypic tolerance, with particular emphasis on biofilm mediated resistance, and present new pipelines of antifungal drugs that promise new hope in the management of C. auris infection.

AB - The enigmatic yeast Candida auris has emerged over the last decade and rapidly penetrated into our consciousness. The global threat from this multidrug resistant yeast has generated a call to arms from within the medical mycology community. Over the past decade our understanding of how this yeast has spread globally, its clinical importance, and how it tolerates and resists antifungal agents has expanded. This review highlights the clinical importance of antifungal resistance in C. auris and explores our current understanding of the mechanisms associated with azole, polyene and echinocandin resistance. We also discuss the impact of phenotypic tolerance, with particular emphasis on biofilm mediated resistance, and present new pipelines of antifungal drugs that promise new hope in the management of C. auris infection.

M3 - Article

JO - mSphere

JF - mSphere

SN - 2379-5042

ER -